Hepatocellular carcinoma (HCC) currently represents the fifth most common malignancy and
the third-leading cause of cancer-related death worldwide, with incidence and mortality rates …

The burden of hepatocellular carcinoma (HCC) is highest in East Asia and Africa, although
its incidence and mortality are rapidly rising in the United States and Europe. With the …

Objective To evaluate the performance of machine learning (ML) algorithms and to compare
them with logistic regression for the prediction of risk of cardiovascular diseases (CVDs) …

Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies,
are at a high risk of develo** hepatocellular carcinoma (HCC). Even after complete HCC …

The epidemiology of hepatocellular carcinoma (HCC) is characterized by dynamic temporal
trends, several major established (ie, HCV, HBV, alcohol) and emerging (ie, diabetes …

Background Surveillance for hepatocellular carcinoma (HCC) has level I evidence among
patients with hepatitis B but only level II evidence in patients with cirrhosis. This lack of …

The development of artificial intelligence (AI) has increased dramatically in the last 20 years,
with clinical applications progressively being explored for most of the medical specialties …

Modern medical care produces large volumes of multimodal patient data, which many
clinicians struggle to process and synthesize into actionable knowledge. In recent years …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

Background Abdominal ultrasound fails to detect over one‐fourth of hepatocellular
carcinoma (HCC) at an early stage in patients with cirrhosis. Identifying patients in whom …